Industry News
Related Searches:
Filter by:
1486 - 1500 of 2429 results
March 6, 2009
AEterna Zentaris Inc. signed a development, commercialization and licensing agreement with Sanofi-Aventis for cetrorelix in benign prostatic hyperplasia (BPH) for the U.S. market.
Read More »
March 6, 2009
Formatech has added a second GMP lyophilizer, increasing its aseptic fill and finish capacity for lyophilized drug products.
Read More »
March 5, 2009
TcL Pharma and Lonza have signed a development and supply contract for TcL Pharma’s lead drug candidate, a monoclonal antibody that adjusts the immune system for the potential treatment of graft rejections and patients with auto-immune diseases.
Read More »
March 5, 2009
PharmaNet Development Group, Inc. has announced its new clinical development human resourcing business, PharmaNet Resource Solutions, offering clinical operations and contract staffing management services.
Read More »
March 4, 2009
Vertex Pharmaceuticals has entered a definitive agreement to acquire ViroChem Pharma in a stock and cash transaction worth $376 million.
Read More »
March 3, 2009
Pfizer has entered into a series of agreements with Aurobindo Pharma Ltd., an India-based pharmaceutical company, to commercialize generics in the U.S. and Europe.
Read More »
March 2, 2009
Pfizer has entered into a technology license and evaluation agreement with Xencor, Inc. to optimize its therapeutic monoclonal antibodies.
Read More »
March 2, 2009
Sinovac Biotech Ltd. has received GMP certification from the China’s State Food and Drug Administration (SFDA) for its filling and packaging production facility.
Read More »
February 27, 2009
Genzyme received approval from the European Commission for the production of Myozyme (alglucosidase alfa) at the 4000 liter bioreactor scale at its manufacturing facility in Geel, Belgium.
Read More »
February 26, 2009
Covance is expanding its biotechnology services facility in Harrogate, UK. The company also received a cGMP Manufacturing License from the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK.
Read More »
February 26, 2009
Akela Pharma's wholly owned subsidiary, PharmaForm, has signed a development agreement with an undisclosed global pharmaceutical company, to develop specialized oral dosage forms at its Austin, TX facility.
Read More »
February 25, 2009
Elan, as part of its restructuring efforts to manage costs and make additional investments in its pipeline, will suspend biologics manufacturing activities and cut approximately 230 positions, or 14% of the company’s workforce.
Read More »
February 25, 2009
Otsuka America Pharmaceutical, Inc. (OAPI) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) will restructure in an effort to grow the pharmaceutical business worldwide.
Read More »
February 23, 2009
Orexo AB will acquire PharmaKodex Ltd., a UK-based drug delivery company with several ready-to-partner preclinical and early clinical projects focused on improving oral, sublingual and transdermal medication.
Read More »
February 20, 2009
UCB plans to build a biologics pilot plant at its site Braine-l'Alleud in Belgium, as part of the company's efforts to focus on central nervous system (CNS) and immunology.
Read More »
1486 - 1500 of 2429 results
